A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome

Summary

The study will investigate the effects and the safety of a single-dose of ABX-1431 HCl on tics and other symptoms of Tourette Syndrome. During part 1 (periods 1 and 2) each patient will receive study drug once and placebo once. Patients who complete part 1 with adequate clinical safety will be offered the option to participate in part 2 (periods 3 and 4) and again willl receive study drug once and placebo once where, in contrast to part 1, administration will take place with a standard high fat meal.

Timeline

Start

2017-02-01

Primary completion

2017-10-04

Completion

2017-10-04

Drugs

Indications